NeuroscienceNature CommunicationsPeer-reviewed
Pharmacogenomic screening identifies and repurposes leucovorin and dyclonine as pro-oligodendrogenic compounds in brain repair
Jean-Baptiste Huré, Louis Foucault, Litsa Maria Ghayad…·Carlos M. Parras
This paper identifies leucovorin and dyclonine as pro-oligodendrogenic compounds through pharmacogenomic screening and validates their therapeutic potential in mouse models of myelin pathologies.
11 citations